ClinicalTrials.gg
Drug

Methoxsalen clinical trials

Also written Uvadex.

studies test it
19
open now
4
in phase 3
2
first study started
1996

Counted the way a researcher would: Methoxsalen with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Methoxsalen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Methoxsalen studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
3 Dec 1954 · 8-MOP · NDA 009048 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Methoxsalen
11

Brand

Uvadex
10
8-mop
1

Other names

8-methoxypsoralen
1

Studies by the year they started

18 studies that test it; most in 2002 (2)

Studies that test Methoxsalen, by start year
YearStudies
19961
20022
20031
20042
20091
20111
20131
20141
20161
20202
20211
20241
20252
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
1
Phase 2
14
Phase 3
2
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 10

Mallinckrodt (5) · Therakos LLC (2) · Universitätsklinikum Hamburg-Eppendorf (1) · Medical University of Graz (1) · M.D. Anderson Cancer Center (1) · National Center for Research Resources (NCRR) (1) · Therakos (1) · Central Hospital, Nancy, France (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Methoxsalen.

Studies

Open first, then newest update. How each study uses Methoxsalen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

Given beside what is tested · 3 — Methoxsalen is usual care or a partner of the new treatment

Codes

What other systems call Methoxsalen · ClinicalTrials.gg INT007810

  • MeSH (NLM) D008730MethoxsalenConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) U4VJ29L7BQMETHOXSALENConfirmed FDA, NLM, Wikidata
  • RxNorm 6854Confirmed FDA, Wikidata
  • Wikidata Q408570methoxsalenConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C643MethoxsalenOne source FDA
  • DrugBank DB00553One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.